NuVasive Spine Foundation Exceeds $18 Million In Global Effort To Support Spine Surgery Patients In Need

The NSF’s Record Fundraising to Provide Life-Changing Spine Surgeries to
Disadvantaged Global Communities

SAN DIEGO, CA – September 30, 2015 – NuVasive, Inc. (NASDAQ: NUVA), a leading medical device company focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, is proud to announce that the NuVasive Spine Foundation™ (NSF), a non-profit organization founded and managed by the Company, has reached a cumulative milestone of approximately $18.4 million contributed since the Foundation’s inception in 2009.  To date, NuVasive has donated approximately $14.8 million in surgical products.  The announcement follows the successful completion of the 8th Annual NuVasive Spine Foundation San Diego Golf Tournament held at the Maderas Golf Club on August 23, 2015.

The Foundation’s annual flagship fundraising event supports the organization’s mission to bring world-class surgeons and innovative spine surgery to disadvantaged communities locally and across the globe. In the past six years, the Foundation’s philanthropic impact has expanded from providing surgical services to a single village outside Nairobi, Kenya to supporting 80 surgical mission trips to patients in 28 countries including Kenya, Belize, India, Nepal, Ethiopia, Syria, Turkey, Romania, Belize, El Salvador, Haiti and Zimbabwe, among other countries

“NuVasive has an incredibly strong corporate culture and one that exemplifies an “attitude of gratitude” spirit that embraces giving back to the community.  This year’s annual golf tournament generated record donations thanks to the shared commitment and generosity displayed by the San Diego business community, our Shareowners who donate their time and money to this cause, and our national business partners, all of whom have contributed so much over the years,” said Gregory T. Lucier, NuVasive’s Chairman and Chief Executive Officer.  “NuVasive has advanced cutting-edge spine technologies that reflect our deep commitment to improving patient outcomes all over the world with the NuVasive Spine Foundation providing us an exceptional opportunity to offer life-changing surgeries to communities in need.  We are very gratified to be able to continue our work in regions of need across the globe and provide advanced care to those in need through the tremendous efforts of NSF.”

In addition to organizing the surgeons who volunteer their time and expertise to further the NSF mission, the Foundation also emphasizes “expertise transfer” to ensure that surgeons in disadvantaged communities are able to create self-sustaining spinal surgery programs once a mission trip concludes.

This year’s golf tournament raised a record $377,000.  Donations resulting from this tournament will provide disadvantaged communities with access to spinal procedures through the funding of mission trips, the sponsoring of patient treatments and the purchasing of essential medical equipment for hospitals and clinics.  The number of yearly missions has more than doubled since 2011 and the Foundation is on track to continue to expand its program development.

About The NuVasive Spine Foundation

The NuVasive Spine Foundation, created by local San Diego spine company, NuVasive, combines cutting-edge technology and a network of world-class spine surgeons to provide life-changing spine surgery to individuals around the world who have limited access to medical treatment.  The organization focuses on developing sustainable spine care programs and advancing spine surgery technology by training and educating surgeons in disadvantaged communities.  For more information about The NuVasive Spine Foundation, visit

About NuVasive

NuVasive is an innovative global medical device company that is changing spine surgery with minimally disruptive surgical products and procedurally-integrated solutions for the spine.  NuVasive has emerged from a small startup to become the #3 player in the $9 billion global spine market and remains focused on market share-taking strategies as the Company continues on its path to become the industry’s leading spine company.  NuVasive offers a comprehensive spine portfolio of more than 90 unique products developed to improve spine surgery and patient outcomes. The Company’s principal procedural solution is its Maximum Access Surgery, or MAS®, platform for lateral spine fusion.  MAS was designed to provide safer, reproducible, and clinically proven outcomes, and is a highly differentiated solution with fully integrated neuromonitoring, customizable exposure, and a broad offering of application-specific implants and fixation devices designed to address a variety of pathologies.

NuVasive cautions you that statements included in this news release that are not a description of historical facts are forward-looking statements that involve risks, uncertainties, assumptions and other factors which, if they do not materialize or prove correct, could cause NuVasive’s results to differ materially from historical results or those expressed or implied by such forward-looking statements.  The potential risks and uncertainties which contribute to the uncertain nature of these statements include, among others, risks associated with acceptance of the Company’s surgical products and procedures by spine surgeons, development and acceptance of new products or product enhancements, clinical and statistical verification of the benefits achieved via the use of NuVasive’s products (including the iGA™ platform), the Company’s ability to effectually manage inventory as it continues to release new products, its ability to recruit and retain management and key personnel, and the other risks and uncertainties described in NuVasive’s news releases and periodic filings with the Securities and Exchange Commission. NuVasive’s public filings with the Securities and Exchange Commission are available at NuVasive assumes no obligation to update any forward-looking statement to reflect events or circumstances arising after the date on which it was made.

# # #

Investor/Media Contact:
Stacy Roughan
NuVasive, Inc.
[email protected]


Previous PostNext Post